文献速递腹部MR

MRI辅助特征用于LI-RADS 3类和4类观察指标:改进分类以提示肝脏恶性肿瘤风险

MRI Ancillary Features for LI-RADS Category 3 and 4 Observations: Improved Categorization to Indicate the Risk of Hepatic Malignancy.
PubMed 文献 · AJR Am J Roentgenol · 2020-10-14

本回顾性纵向研究纳入80例高危患者的106个LR-3或LR-4观察指标,分析仅用主要特征与加用辅助特征调整后的分类对恶性肿瘤风险的提示作用。最终分类为LR-4的观察指标恶性肿瘤累积发生率高于LR-3,且仅用主要特征分类时LR-3与LR-4间无差异;在主要特征分类为LR-3的观察指标中,升级为LR-4者恶性肿瘤累积发生率高于维持LR-3者。结论认为辅助特征调整后的最终分类有助于提示LR-3和LR-4观察指标的恶性肿瘤风险。

要点

  • 仅用主要特征分类时LR-3与LR-4的恶性肿瘤累积发生率无显著差异(p=0.12)。
  • 辅助特征调整后最终LR-4的恶性肿瘤累积发生率高于最终LR-3(p<0.001)。
  • 主要特征LR-3中升级为LR-4者恶性肿瘤风险高于维持LR-3者(p=0.03)。

关键影像表现/征象

  • 在主要特征分类为LR-3的观察指标中,升级为LR-4者与维持LR-3者在限制性扩散和轻度至中度T2加权高信号的出现频率上存在差异(两者p均<0.001)。

诊断标准与关键数值

  • 6个月随访时,初始分类为LR-4的观察指标恶性肿瘤累积发生率为62.5%。
  • 6个月随访时,升级为LR-4的观察指标恶性肿瘤累积发生率为29.7%。
  • 6个月随访时,初始分类为LR-3的观察指标恶性肿瘤累积发生率为6.2%。
  • 6个月随访时,降级为LR-3的观察指标恶性肿瘤累积发生率为0%。
  • 仅用主要特征分类的LR-3与LR-4观察指标之间恶性肿瘤累积发生率无显著差异(p=0.12)。

临床应用与阅片要点

  • 在LR-3和LR-4观察指标的MRI报告中,可结合辅助特征进行调整分类,以更好提示恶性肿瘤风险。
  • 主要特征分类为LR-3的观察指标若出现限制性扩散或轻度至中度T2加权高信号,可能提示需要升级为LR-4。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE. The purpose of this study was to investigate whether ancillary features can help stratify malignancy risk in Liver Imaging Reporting and Data System (LI-RADS) category 3 (LR-3) and 4 (LR-4) observations. MATERIALS AND METHODS. This retrospective longitudinal study included 106 LR-3 or LR-4 observations on gadolinium-enhanced MRI obtained from January 2014 to December 2015 in 80 patients who were treatment naïve and at risk (mean age, 58.0 ± 10.7 [SD] years; 60 men). The presence of major and ancillary features, the category determined using only major features, and the final category adjusted by the application of ancillary features were retrospectively analyzed. MRI features were compared using generalized estimating equations, and cumulative incidence curves for malignancy were compared using log-rank tests with a resampling extension. RESULTS. At 6-month follow-up, the cumulative incidence of observations initially categorized as LR-4, observations upgraded to LR-4, observations initially categorized as LR-3, and observations downgraded to LR-3 were 62.5%, 29.7%, 6.2%, and 0%, respectively. The cumulative incidence of malignancy did not differ between observations categorized by major feature as LR-3 and LR-4 (p = 0.12), but was higher in final observations categorized as LR-4 than in those categorized as LR-3 (p < 0.001). Among observations categorized by major feature as LR-3, the cumulative incidence of malignancy was higher in observations upgraded to LR-4 than in observations that were initially graded as LR-3 (p = 0.03), which showed differences in the frequency of restricted diffusion and mild-to-moderate T2-weighted hyperintensity (p < 0.001 for both). CONCLUSION. Final categories determined with ancillary features, instead of categories determined by major features only, can help indicate malignancy risk in LR-3 and LR-4 observations on MRI.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Kim YY, Choi JY, Kim SU, et al. MRI Ancillary Features for LI-RADS Category 3 and 4 Observations: Improved Categorization to Indicate the Risk of Hepatic Malignancy. AJR Am J Roentgenol. 2020. PMID: 33052732. doi:10.2214/AJR.20.22802

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。